Description
The global human coagulation factor market was estimated at USD 9,875.4 million in 2021 and is projected to reach USD 15,930.3 million by 2028, showing a CAGR of 6.0% during the forecast period 2022-2028. The major elements driving the market growth include the growing patient population base, R&D movements, and increasing emphasis on recombinant products by pharmaceutical companies. Arising markets offer considerable growth opportunities for the global coagulation factor market.
What is Human Coagulation Factor?
Human Coagulation factors are proteins in the blood that aid control bleeding. You have several various coagulation factors in your blood. When you have an injured or another cut that causes bleeding, your coagulation factors work jointly to form a blood clot. The clot controls you from losing too much blood. This procedure is called the coagulation cascade. Blood coagulation is a complicated, multi-step procedure that needs many other various coagulation factors. These factors must work jointly in a coordinated series to produce a blood clot when there is harm to the blood vessels. The clotting procedure can be fast and efficient.
